Clinical Trials
41 trialsFocal Laser Ablation of Prostate Cancer
Jonsson Comprehensive Cancer Center
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Testosterone Therapy in Castration Resistant Prostate Cancer
University of Colorado, Denver
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NTA-476
Melbourne Theranostic Innovation Centre
Re-treatment 225Ac-J591 for mCRPC
Weill Medical College of Cornell University
Neo-Red-P
Columbia University
PIONEER PSMA
Urology Clinics of North Texas
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
University of Utah
Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
City of Hope Medical Center
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Mayo Clinic
WINGMEN
University of Oxford
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
Sichuan University
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
University of Wisconsin, Madison
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC
University of Iowa
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Cisplatin in Castration Resistant Prostate Cancer
University of Rochester
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
University of Wisconsin, Madison
CUPID
Telix Pharmaceuticals (Innovations) Pty Limited
Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer
Ratio Therapeutics, Inc.
BR55 in Prostate Cancer: an Exploratory Clinical Trial
Bracco Diagnostics, Inc
Gallium-68 Citrate PET Used in Prostate Cancer
University of California, San Francisco
68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Streaming Web-based Exercise At Home: A Pilot Study
Cedars-Sinai Medical Center
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion
University of California, San Francisco
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
Cedars-Sinai Medical Center
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Five Eleven Pharma, Inc.
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
Stony Brook University
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
CMX Research
MSG PSMA PET
Jonsson Comprehensive Cancer Center
FLA
Jonsson Comprehensive Cancer Center
Intensity Modulated Radiation Therapy for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
18F-DCFBC PET/CT in Prostate Cancer
National Institutes of Health Clinical Center (CC)
A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MAGNABLATE I
University College London Hospitals
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Mayo Clinic
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Rigshospitalet, Denmark
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
National Cancer Institute (NCI)